The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

The use of actovegin in the neuroprotective treatment of patients with cerebrovascular diseases

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2013;113(6): 74‑76

Read: 5673 times

Download PDF (RU)
Contact the author
Table of contents

THE USE OF ACTOVEGIN IN THE NEUROPROTECTIVE TREATMENT OF PATIENTS WITH CEREBROVASCULAR DISEASES
THE USE OF ACTOVEGIN IN THE NEUROPROTECTIVE TREATMENT OF PATIENTS WITH CEREBROVASCULAR DISEASES

To cite this article:

The use of actovegin in the neuroprotective treatment of patients with cerebrovascular diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2013;113(6):74‑76. (In Russ.)

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Differential diagnosis of Alzheimer’s disease and vascular cognitive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):26-35
Painful diabetic poly­neuropathy in patients with cere­brovascular diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):64-72
Algo­rithm for the diagnosis and treatment of patients with diabetic poly­neuropathy. Expert Council Reso­lution (March 1, 2025). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):102-113
Epileptogenesis and risk factors of symptomatic epileptic seizures in patients with acute cere­brovascular acci­dents. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8-2):26-31
Markers of inflammation and angiogenesis in patients with ischemic stroke after the new coro­navirus infe­ction. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(10):100-103
Neuroprotective therapy in the reha­bilitation phase after ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(12):68-77
Prevalence of cere­brovascular diseases risk factors acco­rding to the cohort survey data in Bishkek, Kyrgyz Repu­blic. Russian Journal of Preventive Medi­cine. 2025;(3):34-39
Dyna­mics of circulatory disease prevalence rates in the working-age popu­lation of the regions of the Ural Fede­ral District in 2012—2023. Russian Journal of Preventive Medi­cine. 2026;(1):14-19
Abstract:

Keywords:

actovegin
neuroprotective treatment
cerebrovascular diseases

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.